Edition:
United States

Ablynx NV (ABLX.BR)

ABLX.BR on Brussels Stock Exchange

11.30EUR
23 Mar 2017
Change (% chg)

€0.14 (+1.25%)
Prev Close
€11.16
Open
€11.26
Day's High
€11.31
Day's Low
€11.00
Volume
155,761
Avg. Vol
165,692
52-wk High
€14.69
52-wk Low
€8.21

Latest Key Developments (Source: Significant Developments)

Ablynx FY revenue rises 10 pct
Thursday, 23 Feb 2017 01:00am EST 

Ablynx Nv : FY total revenues of EUR 85.2 million (+10%) . FY cash position of EUR 235.4 million . FY net cash burn of EUR 72.2 million, in line with previously guided range of EUR 65-75 million . FY net loss EUR 1.1 million versus loss of EUR 54.5 million year ago .FY operating loss EUR 28.6 million versus loss of EUR 17.6 million year ago.  Full Article

Ablynx submits marketing authorisation for caplacizumab
Monday, 6 Feb 2017 01:00am EST 

Ablynx NV : Ablynx submits a marketing authorisation application to the European medicines agency for caplacizumab, its anti-vwf nanobody, for the treatment of aTTP . Ablynx is on track to report results of the confirmatory phase III HERCULES study in the second half of 2017 . In phase II TITAN study, treatment with caplacizumab significantly reduced time to platelet count normalisation and number of recurrences of aTTP while on drug treatment . Intends to lead the commercialisation of caplacizumab in Europe and North America .Post-Hoc analysis of the TITAN study demonstrated that caplacizumab dramatically reduced the number of patients experiencing major thromboembolic events while on drug treatment.  Full Article

Van Herk Investments announces 10.07 pct shareholding in Ablynx
Tuesday, 24 Jan 2017 01:00am EST 

Ablynx Nv :Van Herk Investments B.V. announces 10.07 pct shareholding in Ablynx, an increase from a former position of 5.40 pct (August 2016).  Full Article

Ablynx achieves first milestone in collaboration with Novo Nordisk
Wednesday, 30 Nov 2016 01:00am EST 

Ablynx NV : Ablynx achieves first milestone as part of collaboration with Novo Nordisk . Ablynx to receive 1 million euro ($1.06 million) success fee . Ablynx received an upfront license fee of 5 million euros and will receive up to 4 million euros in research funding during the initial three year research term of the collaboration .Ablynx is eligible to receive potential development, regulatory and commercial milestone payments of up to 182 million euros plus tiered royalties on the annual net sales.  Full Article

FMR LLC announces 9.10 pct shareholding in Ablynx
Friday, 18 Nov 2016 01:00am EST 

Ablynx NV :FMR LLC announces 9.10 pct shareholding in Ablynx.  Full Article

Ablynx H1 net income turns to profit of 22.8 million euros
Thursday, 25 Aug 2016 01:00am EDT 

Ablynx NV : H1 total revenues were 53.5 million euros ($60.3 million), a 39 pct increase compared with 2015 . H1 operating loss reduced to 2.0 million euros, compared with 7.4 million euros in 2015 . H1 net profit of 22.8 million euros versus loss of 15.2 million euros year ago .Outlook for remainder of year confirmed.  Full Article

Bank of America Corporation announce 5.24 pct shareholding in Ablynx
Thursday, 4 Aug 2016 01:00am EDT 

Ablynx NV :Bank of America Corporation announce 5.24 pct shareholding in Ablynx.  Full Article

Ablynx CEO sees potential multibillion-dollar opportunity for drug
Thursday, 7 Jul 2016 04:22am EDT 

Ablynx CEO Edwin Moses told Reuters: Sales opportunity for vobarilizumab could be in "billions" of dollars in rheumatoid arthritis & other diseases . AbbVie will decide later in 2016 whether to license vobarilizumab, after second RA trial results expected in August Further company coverage: [ABLX.BR] (Reporting by UK bureau) ((uk.online@reuters.com;)).  Full Article

Vectura says Ablynx to exercise a license option on Fox device
Tuesday, 28 Jun 2016 04:57am EDT 

Vectura Group Plc :Ablynx to exercise option to license Vectura's Fox device for use in its forthcoming phase IIB efficacy study of its inhaled anti-rsv nanobody.  Full Article

Van Herk Investments announce 3.02 pct shareholding in Ablynx
Thursday, 16 Jun 2016 01:00am EDT 

Ablynx NV :Van Herk Investments announce 3.02 pct shareholding in Ablynx.  Full Article

More From Around the Web

BRIEF-Ablynx FY revenue rises 10 pct

* FY net cash burn of EUR 72.2 million, in line with previously guided range of EUR 65-75 million